OncoEthix's Series B Round

OncoEthix raised a round of funding on July 08, 2013.

OncoEthix is a Swiss-based privately held biotechnology Company that is developing a small portfolio of oncology drug candidates. The Company's lead product, OTX015, is an orally administered syntheti…

Articles about OncoEthix's Series B Round: